Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
Life Science Innovation Northwest 2017 Schedule
Share |

 

Plan your visit to Seattle and Life Science Innovation Northwest 2017! 

 

This is the most up-to-date schedule. More information is forthcoming and schedule to change. If you have any questions about the schedule, please contact Events Manager Katy Tollefson at katy@lifesciencewa.org. Return to main LSINW page here

 


 

Tuesday, May 23, 2017 | Washington State Convention Center 

 

 

Conference Kickoff

 

Registration Opens: 7:00 AM

 

Breakfast Buffet: 7-8:00 AM

 

 

Welcome & Keynote: 8:00 AM

 

Welcome: Caitlin Cameron, CEO, OtoNexus Medical Technologies and Vice Chair, Life Science Washington Board of Directors 

Keynote: Brad Smith, President and Chief Legal Officer, Microsoft

 

 

Morning Sessions

 

 

Podium Presentations: 9:30-11:55 AM

 

 

Big Tech's Big Moves in Healthcare and Life Sciences: 9:30 AM

 

Moderator: Rob Arnold, 3rdMountain, LLC | Speakers: Paul Slater, Microsoft; Hamid Al-Azzawe, Amazon

The Pacific Northwest is an undisputed hub of the technology industry, with long-time anchor companies like Microsoft and Amazon ensuring a constant pool of skilled talent that supports an entire ecosystem of technology innovation. These companies, and others like them, have changed the world by applying the principles of scale and analytics to disrupting multiple industries, yet repeated ventures into life sciences and healthcare have not been met with the same success. Nevertheless, the potential impact of leveraging big tech’s core competencies in life sciences and healthcare – both due to the size of the industry and its importance to our well-being – creates an alluring opportunity that, seemingly, cannot be ignored.

 

Unlocking Data to Open Collaboration in Healthcare and Research: 10:45 AM 

 

Moderator: Jane Roskams, Professor of Neuroscience, University of British Columbia 

Researchers in life sciences and healthcare generate and collect vast amounts of data in the pursuit of ambitious goals such as making life saving discoveries or improving patient care. Importantly, these data can also have value beyond the initial goal for which they were collected, and considering the high cost of life science research there are clear benefits to leveraging the information as much as possible. The high density of healthcare providers, healthcare services, and research institutions in the Pacific Northwest might suggest that opportunities for synergistic collaboration abound, yet anyone who has attempted such collaborations will lament the challenges of collecting, organizing, and integrating data from within a single institution, let alone multiple organizations. 

 

Lunch Session

 

Lunch: 12:00 PM

 

Implications of the New Administration: Science Funding and Policy: 12:30 PM

 

Speakers: Clayton Hall, MDMA; Dr. Jodi Black, NIH; Shawn Bills, State Director for Senator Murray

The next few years will bring a significant shift in federal policy. The United States has a new Republican President along with a Republican-controlled Congress, and leadership changes at all levels of the federal agencies.  This panel will focus on evolving policy changes and the potential downstream effects on the life sciences sector.  

 

 

Afternoon Sessions

 

Podium Presentations: 1:45-4:00 PM

 

Digital Health: Changing Health Behaviors One App at a Time: 1:45 PM

 

Speakers: Patricia Arean, Ph.D.,UW Department of Psychiatry and Behavioral Sciences; David Lischner, ValantMed; Brandon Masterson, 2Morrow, Inc.

The digital health space can be a driver for better health and wellness for the nation, and Seattle—with strong retail and consumer-focused companies—is poised to bring a uniquely innovative spirit to this sector of health care. Increasing access, driving efficiency, supporting wellness—these represent only a part of the promise of this space. Join our distinguished panel for a discussion of an area of digital health that is beginning to generate more traction—behavioral health. 

 

 

Precision Medicine: A Global Perspective: 3:15 PM

 

Within the world’s wealthiest nations, a precision medicine revolution is underway to use advanced diagnostic technologies to ensure each patient gets the right therapy at the right time.  In other regions around the globe, innovative technologies are being used to ensuring access to healthcare.  How will precision medicine technologies help improve the lives of patients in these different healthcare environments?

 

 

Life Science Fast Pitch Showdown: 4:30 PM

 

 

Life Science Innovation Northwest Industry Reception: 5:30 PM

 

 

All Day Sessions

 

Poster Sessions

1:1 Meetings

 


 

Wednesday, May 24, 2017 | Washington State Convention Center 

 

Day 2 Kickoff 

 

Registration: 7:30 AM

Hot Breakfast Buffet & Networking: 7:30-9:00 AM

 

 

Morning Sessions

 

 

What's Hot and What's Not in Life Science Investment? 9:00 AM

 

Moderator: Rita Wang, Piper Jaffrey Healthcare Investment Banking | Speakers: Thong Le, Accelerator Corp.  Julie Sunderland, Managing Director, Biomatics Capital; Dr. Mostafa Ronagi,  Illumina, Inc.;  Dr. Peter Bisgaard, Novo Ventures; Dr. Jerel Davis, Versant Ventures; Dr. Joshua Resnick, SV Health Investors

 

Join us for a diverse investor panel as we gather critical insights into life science investment environment and emerging models. 

 

 

Antimicrobial Resistance - On the Precipice: 10:30 AM

 

Moderator: Dena Morris, Washington Global Health Alliance | Speakers: Doug Call, WSU Paul G. Allen School for Global Animal Health; Ben Park, Centers for Disease Control and Prevention, Akos Somoskovi, Global Good 

 

 It is estimated that nearly 23-thousand people die in the United States from antimicrobial resistant bacterial infections every year and another 2-million are infected. Globally there may be as many as 700,000 deaths annually. Antimicrobial resistance (AMR) is now such a severe threat that the United Nations held a rare special session last year devoted to AMR, and the Centers for Disease Control is investing in a national infrastructure to detect, respond and contain infections in hospitals and clinics and in communities, as well as our food supply; in 2017 more antibiotics will be consumed by farm animals who end up as our food than by humans creating a double threat. This discussion will frame the challenge and explore the need and progress being made for development of next generation antibiotics, vaccines, and other therapeutics that are desperately needed.

 

 

Podium Presentations: 10:30 AM - 11:50 AM 

 

 

Lunch Session

 

Lunch: 11:45 AM 

 

Life Science Awards Ceremony & Lunch: 11:45 AM  

 

 

Afternoon Sessions

 

Podium Presentations: 1:45 PM - 3:00 PM 

 

Philanthrocapitalism: The Role of Private Funding in Advancing Science: 1:45 PM

 

Speakers: Valerie Conn, Science Philanthropy Alliance, Tom Skalak; Paul G. Allen Frontiers Group; Lynda Stuart, Gates Foundation

Federal funding is important in moving science ahead, however government spending levels are likely to decrease over the next few years.  At the same time, more philanthropists are investing in science and “positive impact” work.  How does this trend help shape the scientific exploration and what role do private funders have in defining the most pressing problems?  This panel will feature speakers from several major organizations including the Gates Foundation, Paul Allen Frontiers Group, and the Science Philanthropy Alliance.

 

 

All Day Sessions

 

Poster Sessions

1:1 Meetings 

 

 

Return to main LSINW page here

 

more Calendar

4/27/2017
2017 LSW Program: Next-Generation Therapeutics for the Treatment of Pain

5/15/2017
2017 Laboratory to Leadership - Spring

Featured Partners
BioTech Primer Inc.BioTech Primer develops and delivers customized training to the Life Sciences community

Membership Management Software Powered by YourMembership  ::  Legal